Join over 2,000+ Investors
Register now and embark on your journey to informed and successful investing.
IMUC | US
0.00
1.45%
Healthcare
Biotechnology
31/12/2022
18/10/2024
0.14
0.08
0.14
0.08
Immunocellular Therapeutics Ltd. a clinical-stage pharmaceutical company focuses on the development of therapeutics and delivery technologies for the treatment of inflammatory conditions and ocular diseases. Its lead clinical asset is EOM613 solution a peptide nucleic-acid solution with anti-inflammatory and pro-inflammatory effects on cytokines and chemokines for the treatment of cancer cachexia and rheumatoid arthritis. The company also develops EOM 147 an investigational broad-spectrum aminosterol with an intracellular mechanism for the treatment of chronic and debilitating retinal diseases. Immunocellular Therapeutics Ltd. was founded in 2020 and is headquartered in Montvale New Jersey.
View LessLow Debt to Equity (< 0.25)
Value Stock (Price to Book < 3)
High 6-Month Volatility (>65%)
Microcap (<300M USD)
High Market Beta (> 0.8)
Weak Sharpe Ratio (< 0.3)
Bearish: Increased Volatility (6-month > 1-month volatility)
10 days
354.9%1 month
438.4%3 months
449.9%6 months
509.8%0.02
-
0.35
-0.83
4.51
-3.81
-
-
-6.07M
23.43M
23.43M
-
-
-
-
-2.31K
4.13
3.96
Short-term: Bullish (SMA10D > SMA1M)
Intermediate-term: Bearish (SMA1M < SMA3M)
Long-term: Bearish (SMA6M < SMA12M)
Range10D
0.06
Range1M
0.06
Range3M
0.09
Rel. volume
0.35
Price X volume
70.14
Name | Ticker | Industry | Close | Marketcap | Day Return | PE Ratio | Debt to Equity |
---|---|---|---|---|---|---|---|
Klotho Neurosciences Inc. | KLTO | Biotechnology | 0.7574 | 25.75M | 28.37% | n/a | 0.00% |
Common Stock | NRBO | Biotechnology | 3.03 | 25.72M | -4.11% | n/a | 0.90% |
CytoMed Therapeutics Limited Ordinary Shares | GDTC | Biotechnology | 2.22 | 25.62M | 4.22% | n/a | 3.98% |
Tonix Pharmaceuticals Holding Corp | TNXP | Biotechnology | 0.18 | 25.20M | 0.33% | n/a | 21.99% |
iBio Inc | IBIO | Biotechnology | 2.87 | 24.79M | 0.70% | n/a | 20.92% |
Caladrius Biosciences Inc | LSTA | Biotechnology | 2.97 | 24.71M | 1.02% | n/a | 0.58% |
PolyPid Ltd | PYPD | Biotechnology | 3.59 | 24.71M | 4.66% | n/a | 689.01% |
RenovoRx Inc. Common Stock | RNXT | Biotechnology | 1 | 23.99M | 0.00% | n/a | 0.00% |
Bolt Technology Corp | BOLT | Biotechnology | 0.6264 | 23.97M | -1.82% | n/a | 22.00% |
Aligos Therapeutics Inc | ALGS | Biotechnology | 7.25 | 23.17M | 0.55% | n/a | 14.63% |
Name | Ticker | Industry | Close | Marketcap | Day Return | PE Ratio | Debt to Equity |
---|---|---|---|---|---|---|---|
Beasley Broadcast Group Inc | BBGI | Broadcasting - Radio | 12.9 | 19.65M | 2.38% | n/a | 204.46% |
ILAG | ILAG | Building Products & Equipment | 1.03 | 18.60M | 5.10% | n/a | 5.48% |
Antelope Enterprise Holdings Limited | AEHL | Building Products & Equipment | 0.538 | 7.80M | -6.65% | 0.04 | 16.03% |
Forza X1 Inc | FRZA | Recreational Vehicles | 0.2201 | 3.95M | 4.26% | n/a | 0.97% |
EZGO Technologies Ltd. Ordinary Shares | EZGO | Recreational Vehicles | 1.06 | 2.76M | 1.92% | n/a | 9.62% |
Micromobility.com Inc. | MCOM | Recreational Vehicles | 0.01 | 897.66K | -12.28% | n/a | -37.05% |
Winnebago Industries Inc | WGO | Recreational Vehicles | 60.38 | 0 | 0.37% | n/a | |
Vision Marine Technologies Inc | VMAR | Recreational Vehicles | 3.92 | 0 | -8.84% | n/a | |
Twin Vee PowerCats Co. Common Stock | VEEE | Recreational Vehicles | 0.4801 | 0 | -10.26% | n/a | |
Urban One Inc | UONEK | Broadcasting - Radio | 1.045 | 0 | -2.34% | n/a |
Parameter | Company | Industry | Indicator |
---|---|---|---|
Enterprise to EBITDA | -3.81 | 0.53 | Cheaper |
Ent. to Revenue | - | 4,005.99 | - |
PE Ratio | 0.02 | 40.42 | Cheaper |
Price to Book | 0.35 | 15.30 | Cheaper |
Dividend Yield | - | 2.20 | - |
Std. Deviation (3M) | 449.92 | 72.92 | Riskier |
Debt to Equity | -0.83 | -1.24 | Expensive |
Debt to Assets | 4.51 | 0.25 | Expensive |
Market Cap | 23.43M | 3.78B | Emerging |